January 12, 2012 – Varian Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a new radiotherapy treatment planning tool designed to work with the company's Eclipse treatment planning software to reduce the amount of time needed for planning advanced treatments.

"In order to create a customized treatment plan, a clinician must take the patient's anatomical images and identify and outline the tumor and nearby organs in a process called contouring. This is critical when specifying what is to be irradiated or protected during radiotherapy treatments," said Jefferson Amacker, director, clinical solutions. "Traditionally, contouring has been a time-consuming process."

Varian has combined two techniques in Smart Segmentation Knowledge-Based Contouring, making it possible for clinicians to accomplish the contouring process more quickly:

  1. Smart Segmentation, which analyzes anatomical images, drawing on information about human anatomy to identify and outline organs and other structures, and
  2. Knowledge-Based Contouring, which allows the clinician to start the planning process by drawing on a library of expertly pre-contoured images that have important anatomical structures already outlined. The clinician then follows a special process for matching these pre-contoured images with those of the patient to create the desired contours.

"It's similar to building a house from scratch or remodeling. Remodeling is generally faster because you have something to work from," said Amacker. "Both of these tools give clinicians a head start, so that the contouring task can be more easily and quickly completed."

Smart Segmentation KBC can be used in conjunction with Varian's Eclipse treatment planning system to create treatment plans for external beam or for brachytherapy treatments. The Knowledge Based Contouring tool contains an anatomy atlas that covers all of the areas of the body most commonly treated with radiotherapy when cancer has been detected, including the breast, prostate, gynecological, lung, brain, head and neck, and many other areas of the body. Eclipse has been adopted for radiotherapy treatment planning at more than 3,000 radiation oncology clinics around the world.

For more information: www.varian.com

 


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now